SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-29
👔
Adaptive Biotechnologies Corp
@ADPT_InsiderForm 4 Filing: GRIFFIN MICHELLE RENEE Sells $1.5M of $ADPT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Adaptive Biotechnologies Corp
Ticker: $ADPT
Transaction Value
$1.5M
Price/Share: $13.99
transaction date
2026-06-25
Shares: 104,168
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GRIFFIN MICHELLE RENEE, holds the title of Director at Adaptive Biotechnologies Corp.
On 2026-06-25, the insider transacted 104,168 shares.The shares were transacted at a weighted average price of $13.99 per share, resulting in a total market-relevant value of $1.5M.
Executive Summary Summary
GRIFFIN MICHELLE RENEE (Director) sold $1.5M of $ADPT
Post-Transaction Position: 15,625 shares
SEC Accession No: 0001229765-26-000008 (CIK: 1229765)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.